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Background: The reactions between Complex IV (cytochrome c oxidase, CcOX) and nitric oxide (NO) were de-
scribed in the early 60's. The perception, however, that NO could be responsible for physiological or patho-
logical effects, including those on mitochondria, lags behind the 80's, when the identity of the endothelial
derived relaxing factor (EDRF) and NO synthesis by the NO synthases were discovered. NO controls mito-
chondrial respiration, and cytotoxic as well as cytoprotective effects have been described. The depression
of OXPHOS ATP synthesis has been observed, attributed to the inhibition of mitochondrial Complex I and IV
particularly, found responsible of major effects. Scope of review: The review is focused on CcOX and NO
with some hints about pathophysiological implications. The reactions of interest are reviewed, with special
attention to the molecular mechanisms underlying the effects of NO observed on cytochrome c oxidase,
particularly during turnover with oxygen and reductants. Major conclusions and general signiﬁcance: The
NO inhibition of CcOX is rapid and reversible and may occur in competition with oxygen. Inhibition takes
place following two pathways leading to formation of either a relatively stable nitrosyl-derivative (CcOX-
NO) of the enzyme reduced, or a more labile nitrite-derivative (CcOX-NO2−) of the enzyme oxidized, and dur-
ing turnover. The pathway that prevails depends on the turnover conditions and concentration of NO and
physiological substrates, cytochrome c and O2. All evidence suggests that these parameters are crucial in de-
termining the CcOX vs NO reaction pathway prevailing in vivo, with interesting physiological and patholog-
ical consequences for cells. This article is part of a Special Issue entitled: Respiratory Oxidases.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Most of the biological oxygen reduction is catalyzed by the so-
called terminal oxidases, the last enzymatic complexes in the respira-
tory electron transport chain of aerobic organisms. Terminal oxidases
encompass the large superfamily of heme-copper oxidases, sub-
divided into the A-, B-, and C-families [1], widespread among the
different Life Kingdoms, and the Cu-lacking bd-type oxidases [2,3],
that have been identiﬁed only in prokaryotes. The heme-copper ox-
idases all perform the same oxygen reduction and proton pumping
chemistry [1,4], and accept electrons either from cytochrome c
(cytochrome c oxidase, CcOX — E.C. 1.9.3.1) or from quinols [5,6],
both substrates being in turn reduced by the respiratory complexes
preceding in the chain. In the aerobic world of Eukaryotes, there is
the mitochondrial aa3-type CcOX, containing heme a and heme a3.atory Oxidases.
Biochimiche ‘A. Rossi Fanelli’,
00185 Roma, Italia. Tel.: +39
l rights reserved.Mitochondrial CcOX is reduced by cytochrome c and reduces, in
turn, O2 to water. The electron transfer is electrogenic and coupled
to proton translocation across the inner mitochondrial membrane;
the overall process contributes to build up and maintenance of the
proton electrochemical gradient, ΔμH+~200 mV, used by the ATP
synthase to drive ATP synthesis [7–16].
The overall reaction is:
4 cyt. c2+ + O2+8 H
+
in→ 4 cyt. c
3+ + 2 H2O + 4 H
+
out
Since the late 80's there have been more than 20 years of intense
research on the reactions between terminal oxidases and the nitrogen
monoxide, NO (common name nitric oxide). As other classical respira-
tory chain inhibitors, such as cyanide, NO also inhibits CcOX, but with
themajor difference that NO inhibition reverts completely and quickly
upon removal of this gaseous inhibitor from solution [17–20]. This pe-
culiarity suggests that the NO-inhibition of mitochondrial CcOX can
be better described as a functional control of cell respiration [21–26].
In this paper, we will provide un updated picture of the structural
and functional properties of CcOX, suitable to ﬁgure out how NO
reacts with the enzyme. The detailed molecular mechanisms of
the reactions between CcOX and NO will then follow. Two
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Fig. 1. CcOX the dimer assembly and the redox active metals. The overall 3D structure
of the mammalian enzyme is accommodated into a bilayer (sketched), and oriented
with the cytochrome c binding site on the external surface of the inner mitochondrial
membrane, positively (P) charged compared to the mitochondrial matrix, negatively
(N) charged. The Fe-hemes and coppers in a single monomeric unit (half of the
dimer) are reported in different colors; these redox sites are crucial to the enzymatic
and ligand binding activity of the enzyme. The electron transfer pathway from cyto-
chrome c to the hemea3-CuB via the CuA site and heme a is indicated with small arrows.
From the Protein Data Bank coordinates of the oxidized beef heart CcOX (PDB Id:
2OCC), deposited by Yoshikawa et al. [50].
1 Unless otherwise stated, the amino acid numbering is based on the bovine heart
cytochrome c oxidase sequence.
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tive site of CcOX have long been known; these yield either a nitro-
syl- or a nitrite-CcOX derivative [27,28]. In 2000, using detergent-
solubilised CcOX in turnover, Sarti et al. [29] demonstrated that
these two derivatives accumulate to different extents depending
on the redox steady-state level of the enzyme. As shown therein,
accumulation reﬂects the rate of electron donation by cytochrome
c2+ and withdrawal by O2, a ﬁnding conﬁrmed by the same
group on mitochondria and cells [21,30], and later on further inves-
tigated and substantiated [31–33]. A point that should be kept in
mind is that NO is widely distributed among cells and tissues,
and is also highly permeable to membranes [34]. It is therefore
likely that the NO cell destiny and its body clearance, as such or
as nitrite/nitrate (the main catabolites of higher nitrogen oxides,
NOx), have predictable bioenergetic implication.
At mechanistic level, the experimental conditions favoring one re-
action mechanism or the other, i.e., CcOX nitrosylation or formation
of the nitrite-derivative, may acquire patho-physiological meaning
and have been therefore analyzed in detail.
2. Snapshot of structural and functional properties of CcOX
In mammals, a single monomer of CcOX is made of 13 different
subunits identiﬁed by roman numbering [35], whereas in the more
elementary bacterial enzymes the number of subunits is smaller,
i.e., ≤4 [36,37]. Of these 13 subunits, subunits I, II and III are encoded
by themitochondrial DNA and form the functional core of the enzyme.
These subunits are the largest, ranging from ~30 kDa to 60 kDa [38],
and include all the redox sites, providing also the structural scaffold
essential to the proton pumping machinery. The remaining 10 sub-
units are smaller and encoded in the nucleus [39], performing not
fully understood regulatory roles [40,41]. In particular, Subunits IV
and VIa were proposed to mediate a phosphorylation-dependent
mechanism regulating CcOX activity (reviewed in [42]).
As puriﬁed from beef heart (typically after solubilisation in deter-
gents such as lauryl-maltoside) and crystallized, CcOX exists as a
homo-dimer [35]. The total surface area at the monomer-monomer
interface is ~500 Å. A single monomeric functional unit of the enzyme
contains 5 redox active metal ions, 2 Fe and 3 Cu, forming 4 interact-
ing sites, see Fig. 1. These are organized as follows: at the electron
accepting pole of the enzyme, 2 coppers in the bimetallic CuA site
and 1 Fe-heme a, whereas in the O2-binding active site, 1 Fe-heme
a3 coupled to 1 CuB. This structure is embedded into the inner mito-
chondrial membrane making the intramolecular electron transfer
processes within the protein moiety particularly complex, as the elec-
trons and protons transferred by/through the enzyme contribute to
formation and maintenance of the H+ electrochemical gradient ΔμH+
used by the ATPase (see pdb Id n# 2OCC, for mammalian CcOX and
n#1AR1, for Paracoccus denitriﬁcans). The protein also contains
1 Mg2+ and 1 Ca2+ (reversibly exchanging with Na+ in mammalian
oxidase [43]); moreover 1 Zn2+, 5 phosphatidyl ethanolamines and
3 phosphatidyl glycerols as well as 2 cholate molecules co-purify
with the protein [35].
The Mg2+ ion detected in the bovine enzyme is close to the heme
a3-CuB site, at the interface between subunits I and II [35] and is
substituted by Mn in bacteria [44,45] As recently conﬁrmed [46], the
Mg/Mn site is probably involved in the exit pathway for protons/water
molecules [47,48].
Nowadays, the 3D structure of a number of cytochrome oxidases
native or mutated and in different redox and liganded states has been
solved by X-ray crystallography. The analysis has been performed
on the enzyme puriﬁed from mammals [35,49,50], and bacteria [36,
51–54], the latter in the native or the recombinant form [55]. The
structure of a bo3-type ubiquinol oxidase (from Escherichia coli) is
also available [56], along with that one of the divergent cbb3-type ox-
idase from Pseudomonas stutzeri [57]. The original structural studiescarried out on the wild-type fully oxidized aa3-type enzymes have
been extended to mutants of the K and D proton channels in Rhodobac-
ter sphaeroides [58], and to different redox and ligation states of the en-
zyme [59,60].
As schematically drawn in Fig. 1, at the level of the electron
accepting pole of CcOX, the CuA site contains two copper ions, tightly
coupled. This site, embedded in the subunit II domain protruding into
the mitochondrial intermembrane space (the periplasm in bacteria),
undergoes a one-electron reduction by cytochrome c [61–64]. The
reduced CuA center rapidly donates intramolecularly the electron
to heme a, that is located 19 Å away (CuA-to-Fea distance), buried
within the membrane-embedded domain of the enzyme, such that
its reduction brings the electron close to the midplane of the mem-
brane. The structural transition triggered by the reduction of heme
a, observed by X-ray crystallography at 1.8/1.9 Å resolution [49]
and conﬁrmed by FTIR measurements [65], has been proposed by
Yoshikawa and co-workers to be crucial for proton pumping, involv-
ing D511 in subunit I [49,50,66].
Electrons donated by the reducing substrates are transferred
intra-molecularly from heme a to heme a3 and CuB. In the fully re-
duced state, at 1.9 Å resolution, CcOX displays a trigonal planar coor-
dination of CuB by three histidine residues, one of which is covalently
linked to a tyrosine residue of subunit I (Y244) thereby taking an im-
portant part in the O2 reduction cycle [67,68]. CcOX is targeted and
inhibited by a number of small molecules/ions, such as CN−, CO,
HCOO−, H2S, N3− and NO, that can be accommodated into the active
site of the enzyme [69]. The pathophysiological implications are
quite different and, nowadays, better focussed owing to a clearer un-
derstanding of the mechanisms by which these small ligands react
with the enzyme. Nitric oxide particularly has been shown to be of in-
terest, since it is ubiquitous and able to reversibly inhibit mitochon-
drial respiration (see [17,18,20,21,29,70]).
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lar organisms are almost identical in their key electrostatic and ther-
modynamic properties, all of them performing at least the same
redox chemistry in the presence of reducing substrates and oxygen
[4]. This similarity among terminal oxidases becomes less evident
when considering the reaction with NO: CcOX, for instance, is unable
to reduce efﬁciently NO to dinitrogen monoxide (N2O) [71], different-
ly from T. thermophilus ba3 oxidase, E. coli bo3 quinol oxidase or the
cbb3-type enzyme from P. stutzeri [72–74]. Structural analysis indi-
cates that CcOX is a rigid protein, undergoing small conformational
changes upon redox changes. Taken together, the structural data sug-
gest that heme-copper oxidases all share a conserved bimetallic ac-
tive site (binuclear center) made of a high-spin heme (a3, o3 or b3,
depending on the identity of the enzyme) and a copper ion (called
CuB). This site is where O2 binds and is processed, but also where
NO binds and undergoes redox chemistry [21,22].
In the 3D structure, the fully oxidized enzyme, regardless ofwhether
from beef heart, P. denitriﬁcans, R. sphaeroides or T. thermophilus, dis-
plays an electron density between the iron of heme a3 and CuB. This
density has been related to the presence of different ligands bridging
the two metal ions in the active site, namely it has been assigned to a
(hydro)peroxo species [50] or toH2O andOH− [51]. In the fully reduced
state, or after re-oxidation (pulsing [75]) of the enzyme, the electron
density between the twometals vanishes, indicating ligand dissociation
[49,52]. At higher resolution, 1.95 Å, the 3D structure of the as isolated
bovine heart CcOX appears consistent with the presence of a peroxo
group bridging the twometals [76]. This is also suggested by resonance
Raman measurements showing a band at 755 cm−1 fully compatible
with the O–O stretching mode of a peroxide, bridging the Fe and Cu in
the active site of a fully oxidized, as isolated CcOX [77], but see also
Kaila et al. [78] for an alternative interpretation.
3. The intermediates populated by CcOX during turnover with O2
The assessment of the chemistry of the catalytic CcOX intermedi-
ates has been hard, and in some cases is still a matter of debate, par-
ticularly owing to difﬁculties in assigning the redox state of the
metals in the active site in each species observed during the catalytic
cycle. Although the issue is out of the scope of this paper, a schematic
representation of the species populated during turnover is provided
to help the understanding of the reaction mechanisms by which NO
reacts with CcOX during turnover.
Following electron donation by cytochrome c, electrons are trans-
ferred intramolecularly to the binuclear heme a3-CuB catalytic site.
This site can accept up to two electrons starting from a ferric/cupric
ground state; it can thereby exist in a fully oxidized ([Fea33+CuB2+],
O), in a single-electron reduced ([Fea32+CuB2+] or [Fea33+CuB+], E) and
in a two-electron reduced ([Fea32+CuB+], R) state. O2 binds rapidly to
the R active site yielding the so-called compound A [79]. Compound
A is short-lived, and the very fast delivery of electrons to bound O2
leads to formation of an intermediate, originally proposed to be a per-
oxo species [Fea33+–O–O–CuB2+]. This intermediate was thus called P,
but it rather proved to be a ferryl derivative of heme a3 (Fea34+_O)
with Y244 in the radical form [80–82]. P is in turn converted to the
F intermediate, that is also a ferryl adduct of heme a3 but, differently
from P, has Y244 reduced and protonated. F eventually converts to
the fully oxidized state O upon arrival of an additional electron from
CuA/heme a.
These intermediates react differently with NO, leading to the accu-
mulation of CcOX derivatives characterized by different functional
properties and destiny (see below).
4. The 3D structure of the NO-bound CcOX
In 2010 Muramoto et al. [59] published the 3D structure of the
fully reduced NO-bound CcOX obtained at 100 K, to be comparedwith the structure obtained at 50 K and under illumination by Ohta
K. et al. [83]. As shown in Fig. 2, in the dark and at 100 K, NO binds
to the Fe2+ of heme a3 in a bent end-on coordination structure
(131° in the Fe–N–O angle), whereas under illumination and at 50 K
an electron density is detected in between the CuB and the Fea3, nicely
ﬁtting the NO molecule as drawn by difference with the reduced
CcOX structure [50,83]. As pointed out by the authors and shown in
the ﬁgure, after photodissociation the NO molecule is close, but
not bound, to either Fea3 or CuB indicating that, at least under these
conditions, re-binding is negligible. The structure also conﬁrms that
the chemical bond of NO to the active site, responsible for formation
of the nitrosyl derivative, and assigned by spectroscopy to the re-
duced heme a3 iron, is photolabile [29,84]; moreover, under the con-
ditions explored, NO appears closer to CuB rather than to Fea3 [83].
A pre-requisite for O2 and CO, but not for NO binding, is the com-
plete reduction of the active site (see below). It is worth noticing that,
when the enzyme is puriﬁed in the presence of chloride, there is plen-
ty of time for this ion to bind the binuclear site, where it hinders
(slows down) some reactions [85,86]. Interestingly, upon reduction
of the active site, chloride is released and the site promptly becomes
reactive toward other anions and ligands.5. CcOX and NO during catalysis: the two-mechanisms frame
The reactions of NO with CcOX have long been known [27,28]
and are schematically represented in Fig. 3. The NO produced enzy-
matically by the NO synthases or exogenously added to respiring
cells, organelles or puriﬁed CcOX, proved to be able to inhibit O2 con-
sumption by CcOX [17–20,87], as well as ATP production [88]. Since
ﬁrst observed by time resolved stopped ﬂow spectroscopy [29], it
was suggested that inhibition occurs following two different reaction
pathways, leading to formation of a relatively stable [Fe2+ NO CuB+]
nitrosyl-derivative, or a labile [Fe3+ NO2− CuB?] nitrite-bound deriva-
tive; in the latter derivative the redox state of CuB, transiently re-
duced by NO, is uncertain (see [21] and references therein). It may
be worth to clarify that when O2 and NO are allowed to react at the
same time with CcOX, inhibition by NOmay or may not occur in com-
petition with O2, depending on the fractional distribution of the cata-
lytic intermediates of CcOX. Since O2 can only bind to the fully
reduced, R CcOX binuclear site [89], R is the only intermediate that
can react with both O2 and NO, whereas the O, E, P and F intermedi-
ates can solely react with NO. Therefore, the reaction of NO with these
latter intermediates does not occur in competition with O2, at least
strictly speaking. Indeed, at bulk level, O2 and NO by reacting one
with the other do reciprocally lower their concentration [90]. Based
on these observations, the mechanism by which NO reacts with
CcOX depends on the relative fraction of the catalytic CcOX interme-
diates populated at a given time [91], and in turn on the electron ﬂux
level through CcOX [29]. This original observation has been later on
reproduced, extended and quantiﬁed using different CcOX-containing
systems, at different O2 tensions [31,92], and down to submicromolar
NO concentration values [33].
Common to both mechanisms, the inhibited CcOX recovers its
activity spontaneously in the presence of O2, as NO is slowly but
progressively degraded (oxidized) in solution. Reversal of inhibi-
tion is clearly enhanced in the presence of NO scavengers, such as
myoglobin, hemoglobin or reduced glutathione (GSH), physiologi-
cally present in the cell or exogenously added to the system; the
same result is obtained by speciﬁcally inhibiting the cellular endog-
enous NO production by NO-synthases (NOSs) [93,94].
Given the involvement of NO as a signaling molecule in many
patho-physiological processes, a large number of investigations has
been carried out (reviewed in [21,22,26,32,33,95,96]), showing that
the NO inhibition of the enzyme can occur at all levels, from the isolat-
ed enzyme to mitochondria, cells and tissues [17–20,93,94,97–103].
BH2O
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Fig. 2. X-ray crystallographic structure of the NO-treated bovine heart CcOX. Enzyme fully reduced and NO bound, at 100 K and in the dark (panel A, reproduced from [59]) or at
50 K and under light illumination (panel B, reproduced from [83] with IUCr's copyright permission).
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The reaction of NO with the fully reduced (R) binuclear site yields
a characteristic [Fe2+ NO CuB+] nitrosyl adduct and occurs at a rate
(k=0.4−1×108 M−1 s−1, [27,104]) similar to that of O2. A ﬁrst im-
portant consequence is that, in the presence of NO, all conditions fa-
voring the reduction of the CcOX catalytic site will also favor its
stabilization in the nitrosylated state whose structure has been
reported by Muramoto et al. [59]. The CcOX nitrosyl-adduct is rela-
tively stable and, only upon scavenging free NO in solution, NO is
thermally released unaltered by the reduced enzyme [29,105]. An im-
portant corollary of this ﬁnding is that in eukaryotes the mitochondri-
al CcOX has lost competence in reducing NO to N2O [71]. As reported
above, this ability is retained by some bacterial terminal oxidases
showing a slow, but measurable NO-reductase activity [72–74]; a
ﬁnding consistent with the hypothesis that heme-copper oxidases
and bacterial heme b3-containing NO reductases share a common
phylogenesis [106,107].
The stability of the nitrosyl adduct is peculiar: compared, to hemo-
globin (koff ≈ 10−4–10−5 s−1 at 20 °C), the rate of NO dissociation
from reduced CcOX is unexpectedly high (koff=3.9×10−3 s−1 at
20 °C, [29]) as it is the activity recovery of the enzyme from inhibi-
tion. Interestingly, the nitrosyl adduct is photosensitive and NO is
promptly released from CcOX under (white light) illumination
[29,83,84]. The light-induced NO displacement from CcOX enables
us to study the kinetics of recovery of respiration and to gain insight
into the mechanism of CcOX inhibition by NO, particularly under ex-
perimental conditions unfavorable to UV–visible absorptionspectroscopy, such as in the presence of scattering samples, as intact
cells or mitos [30,108,109].
In the presence of NO, under the redox conditions compatible with
full reduction (R) of the catalytic site, the inhibition is set promptly
and with high afﬁnity (Kd=0.2 nM [31]). Under these turnover con-
ditions, inhibition is set in competition with O2 (because R can react
with both NO and O2) and, upon scavenging NO and/or exposing
the enzyme to O2, the activity is recovered at the rate of NO dissocia-
tion from reduced heme a3, without additional redox chemistry at
the site or involvement of superoxide (O2−•) formation [105,110].
The NO dissociation is much faster from the nitrosyl adduct of
the fully reduced Cu-lacking cytochrome bd oxidase from E. coli
(k=0.133±0.005 s−1 at 20 °C, [111,112]), pointing to a role of CuB
in this reaction, in line with the recent observation by Ohta et al.
[83]. It is worth mentioning that the remarkably higher NO dissocia-
tion rate measured for cytochrome bd suggests that this enzyme
may represent, for those microorganisms able to express it, a defense
mechanism ensuring a higher respiratory resistance to nitrosative
stress [112–115].
The reduction kinetics of heme a3 in the K354M of the Paracoccus
denitriﬁcans is extremely slow so that the O2 reduction activity of
this enzyme is severely impaired. Unexpectedly, however, this mu-
tant binds NO at the reduced heme a3 about two orders of magnitude
more rapidly than O2, suggesting that NO can react also with the sin-
gle-electron reduced (E) binuclear site [116] in line with previous
proposals [117,118]; it remains to be elucidated whether NO directly
targets heme a3 2+ or primarily reacts with CuB+ to be subsequently
transferred intramolecularly to the nearby heme. The whole issue is
Nitrite pathway Nitrosylation pathway
P
Fea34+=O CuB2+
YO-/Y.
F
Fea34+=O CuB2+
YOH
O
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R
Fea32+ CuB+
H+
H+
H+
H+e-
e-
e-
e-
H2O
H2O
O2
E Fea32+ CuB2+
Fea33+ CuB+
1 2
a32+ CuB+ + NO a32+CuB+ NO
a3
3+ CuB2+ +  NO a33+ CuB+ NO+ a33+CuB2+NO2-O, P, F
R
[a3CuB]4+ NOE [a3CuB]4+ +   NO
1
2
2
A
Fea32+O2CuB+
Fig. 3. CcOX catalytic intermediates and the two pathways of reaction with NO. The catalytic cycle of CcOX is schematically reported with the indication of the redox and the oxygen
ligation state of the metals in the active site. The reactions of the intermediates with NO leads to production of the nitrite-bound derivative (1) or the nitrosylated adduct (2). The
Y244 residue, tightly interacting with CuB, is also indicated (see text). The oxidized O species is fully reduced to R, via formation of the half-reduced intermediate E, in which the
electron is either on Fea3 or on CuB. Upon reaction with O2, R converts into A, which decays to F via formation of either PR or PM (depending on whether the initial species is fully
reduced, leading to PR, or mixed valence, leading to PM) reviewed in [69]. Y244 should have radical character in the PM intermediate only. The oxidized O state is restored from F
through further electron transfer. When reacting with the oxidized CuB (intermediates O, P and F), NO yields the (light-insensitive) CcOX-NO2−, nitrite-derivative. Upon binding to
reduced heme a3 (intermediate R) yields the (light-sensitive) CcOX-NO, nitrosyl-derivative.
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with E is unnecessary to account for steady-state data.
5.2. The ‘nitrite’ pathway
Alternatively to the redox-inert binding to the reduced binuclear
site, upon reacting with CcOX, NO can also be oxidized by the binuc-
lear site of intermediates O [86,120], P and F [91,121], generated dur-
ing turnover: in all these cases the reaction end-product proved to be
the nitrite-bound enzyme.
The slow oxidation of NO to nitrite by the CuB in the fully oxidized
(O) CcOX was ﬁrst reported in the early 80's [28]. These authors
assayed the reactivity toward NO of the as isolated, resting CcOX,
a (slow) form [122] of the enzyme displaying different redox and li-
gand binding properties, compared to the so-called pulsed active
(fast) enzyme [75], generated upon exposing the fully reduced resting
enzyme to O2. Cooper et al. [120] found that NO reacts with the pulsed
CcOX much more rapidly (ms) than the resting enzyme; following
the bimolecular collision, one electron is injected by NO into CuB,
thereby rapidly re-equilibrating with heme a via reverse electron
transfer [120]. In the fast reaction (ms), NO is oxidized to nitrosonium
ion (NO+) to be subsequently hydroxylated (or hydrated) to nitrous
acid/nitrite. Eventually the enzyme displays the spectroscopic fea-
tures of the NO2−-bound ferric heme a3 and is inhibited. Later on,
Giuffrè et al. [86] conﬁrmed those ﬁndings and measured the bimolec-
ular rate constant of the reaction of CuB2+with NO (k=2×105 M−1 s−1
at 20 °C); these authors also showed that the oxidized enzyme as isolat-
ed, reacts slowly with NO due to the presence of an external anionic li-
gand (chloride) bound at the oxidized binuclear site during the
puriﬁcation procedure [86]. The CcOX pulsing process, as performed in
the experiments reported by Cooper et al. [120], removes chloride and
other ligands from the enzyme [76,77], thereby allowing fast reaction
with NO [86]. In agreement with the proposal that NO preferentiallyreacts with the oxidized CuB, the oxidized E. coli cytochrome bd, lacking
CuB, reacts with NO very slowly (k=1.5×102 M−1 s−1 at 20 °C) and
without signiﬁcant nitrite production [123].
The in situ formation of NO2− is eventually followed by NO2− bind-
ing to the (nearby) oxidized heme a3. The nitrite-complex formed
under these conditions is inhibited, as shown by standard cytochrome
c oxidation assays, and is optically and functionally undistinguishable
from the complex obtained by addition of a large excess nitrite (NmM)
to the oxidized enzyme [91]. Notably from the functional point of
view, the afﬁnity of nitrite for reduced heme a3 is low [91]. According-
ly, while nitrite dissociation from the oxidized enzyme is very slow
(t1/2~80 min, at 25 °C), upon reduction of the active site, dissociation
of NO2− occurs and activity is promptly restored [91,124].
Relevant to the discussion about the reciprocal control between
CcOX and NO [125], upon reduction of heme a3 during turnover, dis-
sociation of nitrite from the catalytic intermediates is signiﬁcantly
faster (by one order of magnitude) than NO-dissociation from the
same site in the reduced state [29,91].
In conclusion, Torres et al. [121] as well as Giuffrè et al. [91]
reported that NO reacts fairly quickly not only with (chloride-free)
CcOX in the oxidized O state, but also with the enzyme in the P and
F state, all independently generated. The ﬁnal adduct was always
the nitrite-bound CcOX, though the reaction of NO with O proved to
be slightly faster than the same reaction with intermediates P and F
(k=2×105 M−1 s−1 vs k~104 M−1 s−1 at 20 °C). A point that re-
mains to be clariﬁed is whether formation of the nitrite-bound inter-
mediates necessarily involves CuB2+, as originally proposed [86,120].
Interestingly, the ferryl intermediate F of the Azotobacter vinelandii
cytochrome bd oxidase, though lacking CuB, causes the oxidation of
NO to nitrite at a high rate (k=1.2±0.1×105 M−1 s−1 at 20 °C,
[126]). Thus, as reported for other hemeproteins, it is also possible
that NO reacts directly with the ferryl heme a3 of CcOX, without in-
volving CuB [126–128].
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The two reaction pathways between NO and CcOX were indepen-
dently discovered and described more than 30 years ago [27,28,129].
The two pathways coexist and one prevails over the other, depending
on the electron ﬂux level at the CcOX site, as ﬁrst proposed in 2000 by
Sarti et al. [29].
Based on this ﬁrst observation, strengthened by further experi-
mental evidence [30,31,96] and theoretical analyses [31,119,125],
it is agreed that CcOX can react with NO according to two different
reaction pathways: the ﬁrst reaction yields the nitrosyl NO-bound
enzyme, while the second one produces nitrite-bound CcOX. As
just recalled, the reaction of NO with O, P and F is approximately
103 fold slower than NO binding to the fully reduced R binuclear
center (and perhaps to E). It is worth to keep in mind that the
slower kinetics of the reaction of NO with intermediates O, P and
F, is compensated by their predominance under turnover conditions,
when R is expected to be populated only at negligible level [91]. As
expected, the accumulation of the intermediates at any given time
depends on the rate of electron donation by substrates vs the rate
of electron withdrawal by O2, thus ultimately on the overall mito-
chondrial metabolic state, see Antunes et al. [125].
In synthesis, both reaction pathways lead to reversible CcOX inhi-
bition, and activity is restored either by thermal dissociation of NO
from the nitrosyl enzyme [a32+ NO CuB+], the process being slow
(and light-sensitive), or by expelling nitrite from heme a33+ [a33+
NO− CuB
2+], following the electron transfer from heme a to the active
site [91,124,125]. Owing to the different reactivity of CcOX intermedi-
ates toward O2 and NO, the competition between NO and O2 is
expected only when the ‘nitrosyl’ pathway prevails, and not when
the nitrite-bound enzyme is accumulated [29,31,32]. A conclusion
compatible with this synthesis has been recently achieved by Aguirre
et al. [33]. These authors, by using as amodel system iNOS-transfected
HEK 293 cells, and high-resolution respirometry over a wide range of
O2 concentrations, down to nanomolar, conﬁrmed that the NO inhibi-
tion of respiration is always reversible. In agreement with the original
proposal [21,29], later on substantiated [31], Aguirre et al. [33] did not
observe a linear dependence of the IC50 of NO on [O2]. They rather
reported a parabolic dependence of the IC50,NO that was interpreted
as the evidence for the existence of an enzyme adduct accommodating
both a NO and an O2 molecule at the binuclear center. Such an adduct
has been put forward by Pearce et al. [110,130], who suggested that
NO bound to reduced heme a3 in the presence of O2 is ﬁrst metabo-
lized to nitrate (by reaction with superoxide anion formed at CuB)
and then to nitrite prior to dissociation into the bulk. This hypothesis,
however, was not conﬁrmed by others [105] so that the experimental
evidence for such a CcOX adduct with both a NO and an O2 molecule
bound at the active site is still lacking.
7. The biology of the CcOX reaction with NO
The information so far collected on the interaction of CcOX with
NO raises a number of questions relevant to cell biology and, in
turn, to human pathophysiology. Depending on the availability of
NO, O2 and, particularly, reducing equivalents (electrons) entering
the respiratory chain, thus on the reduction level of all the metal
sites in CcOX, the mechanism by which NO reacts with CcOX may
be different, and changes in mitochondrial signaling and metabolism
are plausible.
In this respect, an important issue is whether we can predict
which one of the two reaction pathways described predominates
in intact cells respiring on endogenous substrates upon exposure to
exogenous/endogenous NO. Working with SH-SY5Y neuroblastoma
cells, Mastronicola et al. [30] found that, in the presence of [O2]N
100 μM and under otherwise identical conditions, the ‘nitrite’ path-
ways predominate, unless the electron ﬂux through CcOX isartiﬁcially enhanced (e.g. by tetramethyl-p-phenylenediamine,
TMPD), Fig. 4. As shown in the ﬁgure, the respiration of cells cultured
under standard ‘basal conditions’, i.e., in the presence of (not limit-
ing) O2 and endogenous reducing substrates, is rapidly inhibited fol-
lowing the addition of μM NO. Most notably, upon addition of HbO2
efﬁciently scavenging excess NO, activity recovers immediately: the
kinetics of functional recovery is fully compatible with the nitrite dis-
sociation from reduced heme a3 [29]. The addition to the same cells of
TMPD, in the presence of ascorbate, is able to induce, in a concentra-
tion dependent manner, the appearance of a delay in the kinetics of
recovery of respiration, fully compatible with the monomolecular
NO dissociation reaction from reduced heme a3. The existence of
the nitrosyl-adduct is conﬁrmed by the observation that in the ab-
sence of excess NO (i.e. in the presence of HbO2) recovery can be ac-
celerated shading light on the respiring cells, owing to the light
sensitivity of the NO\Fe2+ bond (see Fig. 4).
In line with this view, Palacios-Callender et al. [23] reported that
human embryonic kidney cells, while respiring toward hypoxia, if
pulsed with small amounts of NO (nM), i.e., under conditions closer
to the physiological ones, do not lose respiratory efﬁciency, while
CcOX becomes signiﬁcantly more reduced indicating that a fraction
of the enzyme is inhibited since involved in the NO oxidation reac-
tion. This phenomenon of compensation, able to keep a suitable respi-
ration level, was described as ‘cushioning’ effect more than 40 years
ago by Britton Chance [131] and was related to the increase in the
reduction level of cytochrome c due to partial inhibition of CcOX
[23,132]. When [O2] becomes limiting, respiration slows down and
eventually stops [23,132].
Thus, the conditions favoring the pathway leading to accumula-
tion of nitrite-CcOX, though variable, must therefore include the pres-
ence of O2 at a concentration compatible with a cell normoxic state
(~10 μM) and of limited amounts of NO (~102 nM) [23]. Under
these conditions, besides the partial inhibition of CcOX that might
even occur without an evident inhibition of respiration, one might
expect a mitochondrial response due to the higher reduction level
of the components of the mitochondrial electron transport chain
[23,132], leading to superoxide and, in turn, hydrogen peroxide
and other ROS production, triggering cell signaling [133].
It is therefore feasible to propose that the overall picture, at
least under the conditions leading to nitrite formation, is more
consistent with a mitochondrial control function exerted by the
reaction of NO with CcOX, a frame more complex than a simple
reversible O2-sensitive inhibition. This issue has been clearly
addressed by Antunes et al. [125], who suggested that the oxida-
tion of NO to nitrite by the oxidized CcOX actually prevents the
inhibitory heme a3 nitrosylation and, perhaps more importantly,
lowers the NO bio-availability.
A completely different behavior is observed when nitrosylation
of CcOX prevails, with accumulation of the nitrosyl [a32+ NO CuB+]
derivative. Experiments aimed at understanding conditions favor-
ing formation of the CcOX-nitrosyl derivative and its functional
recovery were performed using the enzyme differently integrated,
i.e., puriﬁed and detergent solubilized or in situ as in mitochondria
and intact cells [30]. As shown in Fig. 4, in all the experiments,
the parameter critical to drive the CcOX NO-inhibition pathway
toward the enzyme nitrosylation was the concentration of reduc-
tants (cytochrome c2+) provided in the assay. In the presence of
soluble CcOX this parameter was varied by increasing directly
the concentration of cytochrome c2+. In the presence of cells or
mitochondria the fraction of cytochrome c2+ was increased by
using membrane permeable TMPD and excess ascorbate, as reduc-
tants [30,108].
For the mechanistic implications, particularly interesting are the
experiments carried out using a suspension of lymphoblastoid cells
collected from patients affected by Ataxia Telangiectasia (AT), a se-
vere genetic disease characterized by massive radical chemistry
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Fig. 4. Dependence of the CcOX NO inhibition pathway on availability of reductants.
A) Neuroblastoma cells are allowed to respire using endogenous reductants (i.e.,
lower cytochrome c2+ concentration) in the dark. Inhibition of respiration is induced
by addition of 1 μMNO; thereafter, 1 μMHbO2 is added to scavenge free NO and recov-
ery of the O2 consumption activity is immediately observed, suggesting that inhibition
occurred through formation of the CcOX-NO2− derivative. B) Experiments as in panel A,
but carried out upon artiﬁcially increasing the concentration of cytochrome c2+ with
ascorbate and TMPD. The extent of CcOX inhibition, observed (in the dark) at a ﬁxed
time after NO scavenging, increases with TMPD concentration. C) Typical oxygraphic
time course observed in the presence of 1 mM TMPD in the dark (solid) or after illumi-
nation (dashed). Experimental conditions as in panel B. Notice the delay of recovery
after addition of HbO2, in the dark. Inhibition promptly vanishes upon shading light,
due to light-sensitivity of the nitrosyl Fe2+NO adduct [30].
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Fig. 5. NO inhibition of respiration in lymphoid cells (Ataxia Telangiectasia patient)
expressing different amounts of cytochrome c. A) Oxygraphic proﬁles along with
their ﬁrst derivative, of lymphoid cells collected from a patient affected by Ataxia Tel-
angiectasia (AT) and from controls (wt). As in Fig. 4, cells are allowed to respire in
the dark, in the presence of 1 mM TMPD and ascorbate. Inhibition (In) of respiration
is induced by 1 μM exogenous NO; thereafter, 1 μM HbO2 is added to scavenge free
NO. Notice: i) the higher rate of O2 consumption by AT cells before NO inhibition
(Vb) and after its release (Va) matches the higher cytochrome c content of these
cells; ii) the time necessary for AT cells to recover activity (Δt) after addition of HbO2
is longer than for control cells. B) Cytochrome c immunoblotting assays on cell lysates.
Relative Densitometric Intensity (RDI) value of AT and control cells (wt), showing that
everything else being virtually identical, AT cells contain a higher amount of cyto-
chrome c. Modiﬁed from [108].
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trols and everything else being virtually identical, the AT cells are
characterized by an intrinsically higher O2 consumption rate [108].The higher respiration matches a signiﬁcantly higher (~70%) cyto-
chrome c concentration detected in AT cells (Fig. 5). Suggestive of
a higher propensity of AT cells to undergo CcOX nitrosylation, exper-
iments of TMPD titration in the presence of ascorbate (similar to
those presented in Fig. 4), carried out in parallel using AT and control
cells, have shown that AT cells form the CcOX-nitrosyl derivative at a
concentration of TMPD approximately 5 times smaller than controls
[108].
A common ﬁnding in the observations has been that in the presence
of O2 and NO (μM) the pathway of the CcOX inhibition by NO, in the
presence of endogenous reducing substrates, was always nitrite-like
[30]. Upon artiﬁcially increasing the electron ﬂux through the respirato-
ry chain, however, and/or reducing the O2 concentration [31], the O2-
competitive ‘nitrosyl’ pathway tends to take over [29,30]. Mathematical
models [119, 125] further conﬁrmed that experimental data on CcOX
inhibition by NO can be simulated only if both the competitive and un-
competitive pathways are included, with the latter prevailing at lower
617P. Sarti et al. / Biochimica et Biophysica Acta 1817 (2012) 610–619electron ﬂux and higher [O2]. Thewhole picture is compatiblewith sim-
ulations reported byGiuffrè et al. [91] showing that, at lowelectronﬂux,
the overall occupancy of intermediatesO, P and F at steady-state should
increase, thereby favoring the ‘nitrite’ uncompetitive pathway, but see
also Mason et al. [135]. As already mentioned, the O2-competitive inhi-
bition pathway prevails under conditions of high electron ﬂux (turn-
over), when the overall occupancy of R and E tends to increase [91].
The CcOX nitrosyl-derivative is fairly stable at the body tempera-
ture (NO dissociation occurs at koff~10−2 s−1, at 37 °C), thus CcOX in-
hibition becomes more severe when nitrosylation is favored. It is
tempting to speculate that all conditions leading to accumulation
of the CcOX nitrosyl-derivative are compatible with a less efﬁcient
OXPHOS-mediated ATP production that can be compensated, or not,
by production of glycolytic ATP (Warburg effect) [136]. Interestingly,
as pointed out by Almeida et al. [137], different cell lines have different
ATP compensatory efﬁciencies: for instance, astrocytes can compen-
sate glycolytically, whereas neurons cannot. For this very same reason
it has been reasonable to propose that the higher propensity to CcOX
nitrosylation of cells from ataxia telangiectasia patients may contrib-
ute to the severe systemic symptoms of this disease [108].
8. NO/nitrite recycling
The bioavailability of NO to tissues and cells is an important issue.
Besides the NO catalytic production by the NOSs, the chemical or
the catalytic reduction of higher nitrogen oxides (NOx) is also consid-
ered an important route to maintain suitable steady state levels of NO.
In human plasma nitrite is approximately 200 nM and, in equilibrium
with cells and tissues, represents an important buffering source of
NO [138–140].When in tissues the oxygen tension decreases, the abil-
ity of the NOSs to generate NO is compromised by the lack of the O2
substrate. Under these conditions, the anoxic environment promotes
tissue acidiﬁcation, favoring the acidic disproportionation of nitrite
[141,142], as well as the enzymatic reduction of nitrite to NO
[139,143–145]. The question we wish to pose, however, is whether
CcOX takes an active part in the nitrite cell-cycling. The data collected
over the past 20 years, or more, have clearly demonstrated that CcOX
produces nitrite by reacting with NO, particularly under low turnover
(electron ﬂux) conditions and in the presence of O2. This evidence,
alongwith the observation that CcOX is endowedwith anitrite-reductase
activity [146–148], suggests that complex IV participates in maintaining
the mitochondrial nitrite physiological level. Thus, as pointed out by
Antunes et al. [125] it is feasible to assign to the reaction of NO with
the oxidized CcOX a biologic role more complex than the inhibition of
the mitochondrial respiratory chain.
In conclusion, as a side effect of more than 20 years investigation
on the reactions between NO and CcOX, we are facing the intriguing,
provocative, idea that the ofﬁcial classiﬁcation of the enzyme cyto-
chrome c oxidase (EC. 1.9.3.1.) should be updated, since all the exper-
imental evidence shows that CcOX is both an O2 reductase and a
NO oxidase, depending on mitochondrial availability of these, both
physiological substrates.
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